# Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer

> **NCT00002916** · PHASE2 · COMPLETED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 44 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **BIOLOGICAL:** human papillomavirus 16 E7 peptide
- **BIOLOGICAL:** synthetic human papillomavirus 16 E6 peptide
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** surgical procedure
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00002916
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2012-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002916, "Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00002916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*